| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
Activation Requires CD82, Caveolin-1, and Ganglioside1 Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois and Departments of 2 Biochemistry and 3 Oncology, The First Affiliated Hospital, Dalian Medical University, Dalian, Liaoning, China
Requests for reprints: Amy S. Paller, Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, 676 North St. Clair Avenue, Suite 1600, Chicago, IL 60611. Phone: 312-695-3721; Fax: 312-695-0664; E-mail: apaller{at}northwestern.edu.
Activation of protein kinase C (PKC)-
decreases normal and neoplastic cell proliferation by inhibiting epidermal growth factor receptor (EGFR)-related signaling. The molecular interactions upstream to PKC-
that influence its suppression of EGFR, however, are poorly understood. We have found that caveolin-1, tetraspanin CD82, and ganglioside GM3 enable the association of EGFR with PKC-
, ultimately leading to inhibition of EGFR signaling. GM3- and CD82-induced inhibition of EGFR signaling requires PKC-
translocation and serine/threonine phosphorylation, which eventually triggers EGFR Thr654 phosphorylation and receptor internalization. Within this ordered complex of signaling molecules, the ability of CD82 to associate with PKC-
requires the presence of caveolin-1, whereas the interaction of caveolin-1 or PKC-
with EGFR requires the presence of CD82 and ganglioside GM3. Disruption of the membrane with methyl-ß-cyclodextrin dissociates the EGFR/GM3/caveolin-1/CD82/PKC-
complex and prevents the inhibitory effect of PKC-
on EGFR phosphorylation, suggesting that caveolin-1, CD82, and ganglioside interact with EGFR and PKC-
within intact cholesterol-enriched membrane microdomains. Given the role of these membrane molecules in suppressing EGFR signaling, up-regulation of GM3, caveolin-1, and CD82 function may be an effective adjunctive therapy for treating epithelial cell malignancies. [Cancer Res 2007;67(20):9986–95]
This article has been cited by other articles:
![]() |
A. Prinetti, M. Aureli, G. Illuzzi, S. Prioni, V. Nocco, F. Scandroglio, N. Gagliano, G. Tredici, V. Rodriguez-Menendez, V. Chigorno, et al. GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells Glycobiology, January 1, 2010; 20(1): 62 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Liu, P. Sun, Q. Yan, A. S. Paller, P. Gerami, N. Ho, N. Vashi, I. C. Le Poole, and X.-q. Wang De-N-acetyl GM3 Promotes Melanoma Cell Migration and Invasion through Urokinase Plasminogen Activator Receptor Signaling-Dependent MMP-2 Activation Cancer Res., November 15, 2009; 69(22): 8662 - 8669. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Park and H. J. Han Caveolin-1 plays important role in EGF-induced migration and proliferation of mouse embryonic stem cells: involvement of PI3K/Akt and ERK Am J Physiol Cell Physiol, October 1, 2009; 297(4): C935 - C944. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Kim, S.-Y. Park, and H. Pyo Cyclooxygenase-2 (COX-2) Negatively Regulates Expression of Epidermal Growth Factor Receptor and Causes Resistance to Gefitinib in COX-2-Overexpressing Cancer Cells Mol. Cancer Res., August 1, 2009; 7(8): 1367 - 1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schmidt-Glenewinkel, E. Reinz, R. Eils, and N. R. Brady Systems Biological Analysis of Epidermal Growth Factor Receptor Internalization Dynamics for Altered Receptor Levels J. Biol. Chem., June 19, 2009; 284(25): 17243 - 17252. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. White, M. I. Givogri, A. Lopez-Rosas, H. Cao, R. van Breemen, G. Thinakaran, and E. R. Bongarzone Psychosine Accumulates in Membrane Microdomains in the Brain of Krabbe Patients, Disrupting the Raft Architecture J. Neurosci., May 13, 2009; 29(19): 6068 - 6077. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Anastasia, N. Papini, F. Colazzo, G. Palazzolo, C. Tringali, L. Dileo, M. Piccoli, E. Conforti, C. Sitzia, E. Monti, et al. NEU3 Sialidase Strictly Modulates GM3 Levels in Skeletal Myoblasts C2C12 Thus Favoring Their Differentiation and Protecting Them from Apoptosis J. Biol. Chem., December 26, 2008; 283(52): 36265 - 36271. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |